The rounds the web reported this week, verified.
Every row was found by Firecrawl search, extracted with a schema, and checked against its sources before it published. Open a row for the evidence.
/
[ 35 OF 535 ROWS ]
Provides AI workflow tools for real-estate agents
Seed$5M2026-07-02Published on thinner evidence, 1 source
Developer of platform enabling private AI access
Series A$65M2026-07-01Verified against 7 sources
An infrastructure provider for companies running open source models
Series C$800M2026-07-01Verified against 6 sources
Focused on developing air defense technology
Series A$80M2026-07-01Verified against 4 sources
A company that develops AI perception hardware and software platform used in robotics and industrial automation
Series A$14M2026-07-01Verified against 5 sources
A company applying reinforcement learning to trading agents operating in live markets
Series Anot stated2026-07-01Published on thinner evidence, 5 sources
A company that develops robotic AI systems for unstructured manufacturing tasks
Series A$40M2026-07-01Verified against 8 sources
An AI-native sales execution layer for enterprise deals
Series B$60M2026-07-01Verified against 6 sources
A company offering casual mobile games tied to fan fundraising for sports programs
Pre-seednot stated2026-06-30Published on thinner evidence, 2 sources
Building the world’s first fully autonomous robotic pharmacy
Seed$12.6M2026-06-30Verified against 3 sources
A men's professional lacrosse league in North America
Series D+$100M2026-06-30Verified against 6 sources
A provider of tools for tracking enterprise communications to meet regulatory compliance requirements
Growth$180M2026-06-30Verified against 9 sources
A biotech startup targeting transcription factors
Series C$85M2026-06-30Verified against 5 sources
An AI‑driven commercial intelligence platform for consumer‑goods firms
Pre-seed$500K2026-06-30Verified against 3 sources
A startup focused on precision therapies for autoimmune and inflammatory diseases
Series A ext.$126M2026-06-30Verified against 6 sources
Trase offers AI-driven solutions for healthcare, government, and enterprise sectors, focusing on enhancing operational efficiencies and data control through specialized AI agents.
Seed$107M2026-06-25Verified against 6 sources
Insect ingredients for animal nutrition
Undisclosed-stage$58.2M2026-06-24Verified against 3 sources
An agentic decision platform built specifically for financial services
Series C$120M2026-06-22Verified against 1 source
F2 AI sells a platform for financial institutions to manage and analyze private market transactions, allowing users to underwrite and monitor deals efficiently.
Seed$14M2026-06-10Verified against 4 sources
A cryptocurrency financial infrastructure
Seed$6.4M2026-05-21Published on thinner evidence, 2 sources
A company providing persistent aerial intelligence
Series A$17.2M2026-04-14Published on thinner evidence, 2 sources
A biotechnology company focusing on longevity and regenerative medicine
Series D+$80M2026-04-08Published on thinner evidence, 2 sources
Industrial robotics-focused startup
Series A$500M2026-03-11Published on thinner evidence, 1 source
Austin-based humanoid robotics startup
Series A ext.$520M2026-02-11Published on thinner evidence, 1 source
Nilo Therapeutics develops medicines that target neural circuits to restore immune balance in autoimmune and inflammatory disease.
Series A$101M2025-10-08Verified against 2 sources
Dôen sells women's clothing and accessories that embody a vintage-inspired aesthetic, targeting fashion-conscious consumers.
Series Anot stated2025-06-17Published on thinner evidence, 2 sources
An online platform that touches more than 10 million consumers every month
Series D+$158.7M2024-10-14Published on thinner evidence, 2 sources
| Expand | Company | Round | |||
|---|---|---|---|---|---|
Provides AI workflow tools for real-estate agents | Seed Published on thinner evidence, 1 source | $5M | 2026-07-02 Jul 2 | No recent discussion | |
An AI platform for homebuilders | Series C Verified against 3 sources | $95M | 2026-07-02 Jul 2 | No recent discussion | |
Developer of platform enabling private AI access | Series A Verified against 7 sources | $65M | 2026-07-01 Jul 1 | No recent discussion | |
An infrastructure provider for companies running open source models | Series C Verified against 6 sources | $800M | 2026-07-01 Jul 1 | No recent discussion | |
Focused on developing air defense technology | Series A Verified against 4 sources | $80M | 2026-07-01 Jul 1 | No recent discussion | |
A company that develops AI perception hardware and software platform used in robotics and industrial automation | Series A Verified against 5 sources | $14M | 2026-07-01 Jul 1 | No recent discussion | |
seed | Seed Published on thinner evidence, 2 sources | $14.9M | ~ 2026-07-01 that month | No recent discussion | |
A company applying reinforcement learning to trading agents operating in live markets | Series A Published on thinner evidence, 5 sources | not stated | 2026-07-01 Jul 1 | No recent discussion | |
A company that develops robotic AI systems for unstructured manufacturing tasks | Series A Verified against 8 sources | $40M | 2026-07-01 Jul 1 | No recent discussion | |
An AI-native sales execution layer for enterprise deals | Series B Verified against 6 sources | $60M | 2026-07-01 Jul 1 | No recent discussion | |
A company offering casual mobile games tied to fan fundraising for sports programs | Pre-seed Published on thinner evidence, 2 sources | not stated | 2026-06-30 Jun 30 | No recent discussion | |
Building the world’s first fully autonomous robotic pharmacy | Seed Verified against 3 sources | $12.6M | 2026-06-30 Jun 30 | No recent discussion | |
A men's professional lacrosse league in North America | Series D+ Verified against 6 sources | $100M | 2026-06-30 Jun 30 | No recent discussion | |
A provider of tools for tracking enterprise communications to meet regulatory compliance requirements | Growth Verified against 9 sources | $180M | 2026-06-30 Jun 30 | No recent discussion | |
A biotech startup targeting transcription factors | Series C Verified against 5 sources | $85M | 2026-06-30 Jun 30 | No recent discussion | |
An AI‑driven commercial intelligence platform for consumer‑goods firms | Pre-seed Verified against 3 sources | $500K | 2026-06-30 Jun 30 | No recent discussion | |
A startup focused on precision therapies for autoimmune and inflammatory diseases | Series A ext. Verified against 6 sources | $126M | 2026-06-30 Jun 30 | No recent discussion | |
Trase offers AI-driven solutions for healthcare, government, and enterprise sectors, focusing on enhancing operational efficiencies and data control through specialized AI agents. | Seed Verified against 6 sources | $107M | 2026-06-25 Jun 25 | No recent discussion | |
A health-insurance unicorn | Series D+ Published on thinner evidence, 2 sources | $557.9M | 2026-06-25 Jun 25 | No recent discussion | |
A foundational AI startup focused on R&D | Seed Verified against 3 sources | $200M | 2026-06-24 Jun 24 | No recent discussion | |
Insect ingredients for animal nutrition | Undisclosed-stage Verified against 3 sources | $58.2M | 2026-06-24 Jun 24 | No recent discussion | |
An agentic decision platform built specifically for financial services | Series C Verified against 1 source | $120M | 2026-06-22 Jun 22 | No recent discussion | |
AI-powered patent law firm | Seed Verified against 13 sources | $5.5M | 2026-06-10 Jun 10 | No recent discussion | |
F2 AI sells a platform for financial institutions to manage and analyze private market transactions, allowing users to underwrite and monitor deals efficiently. | Seed Verified against 4 sources | $14M | 2026-06-10 Jun 10 | No recent discussion | |
A data centre operator | Series C Verified against 7 sources | $4.5B | 2026-06-05 Jun 5 | No recent discussion | |
An AI biology company | Seed ext. Verified against 2 sources | $14.8M | 2026-06-03 Jun 3 | No recent discussion | |
A cryptocurrency financial infrastructure | Seed Published on thinner evidence, 2 sources | $6.4M | 2026-05-21 May 21 | No recent discussion | |
A company providing persistent aerial intelligence | Series A Published on thinner evidence, 2 sources | $17.2M | 2026-04-14 Apr 14 | No recent discussion | |
A biotechnology company focusing on longevity and regenerative medicine | Series D+ Published on thinner evidence, 2 sources | $80M | 2026-04-08 Apr 8 | No recent discussion | |
Industrial robotics-focused startup | Series A Published on thinner evidence, 1 source | $500M | 2026-03-11 Mar 11 | No recent discussion | |
Austin-based humanoid robotics startup | Series A ext. Published on thinner evidence, 1 source | $520M | 2026-02-11 Feb 11 | No recent discussion | |
Nilo Therapeutics develops medicines that target neural circuits to restore immune balance in autoimmune and inflammatory disease. | Series A Verified against 2 sources | $101M | 2025-10-08 Oct 8 | No recent discussion | |
Dôen sells women's clothing and accessories that embody a vintage-inspired aesthetic, targeting fashion-conscious consumers. | Series A Published on thinner evidence, 2 sources | not stated | 2025-06-17 Jun 17 | No recent discussion | |
Series A | Series A Published on thinner evidence, 1 source | $12M | 2025-02-20 Feb 20 | 1 outlet | |
An online platform that touches more than 10 million consumers every month | Series D+ Published on thinner evidence, 2 sources | $158.7M | 2024-10-14 Oct 14 | No recent discussion |
Records are extracted automatically from public reporting and link to their sources. They can contain errors. Report an error